Literature DB >> 18956525

Contrasting trajectories of heroin, cocaine, and methamphetamine use.

Yih-Ing Hser1, David Huang, Mary-Lynn Brecht, Libo Li, Elizabeth Evans.   

Abstract

Current literature has shown that heroin addiction is characterized by long periods of regular use persisting over the life course, whereas the course of stimulant use is less understood. The current study examined long-term trajectories of drug use for primary heroin, cocaine (crack/powder cocaine), and methamphetamine (meth) users. The analyses used data from five studies that collected longitudinal information using the Natural History Instrument, including 629 primary heroin users, 694 cocaine users, and 474 meth users. Drug use trajectories over the 10 years since initiation demonstrated the persistence of use over time for all three drugs, with heroin use at the highest level (13 to 18 days per month), cocaine at the lowest level (8 to 11 days), and meth in between (approximately 12 days per month). Application of growth mixture models revealed five distinctive groups: Consistently High Use (n = 545), Increasing Use (n = 260), Decreasing Use (n = 254), Moderate Use (n = 638), and Low Use (n = 100). Heroin users were disproportionately overrepresented in the Consistently High Use group and underrepresented in the Low Use group; cocaine and meth users were mostly in the Moderate Use group. Users in the High Use group also had earlier onsets of drug use and crime, longer incarceration durations, and were the least employed. Clinical/service policy and practice need to recognize and adapt to the specific patterns and needs of users of different drugs while being mindful of the stage drug users are at in their life course.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956525      PMCID: PMC2821675          DOI: 10.1080/10550880802122554

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  15 in total

Review 1.  Have we evaluated addiction treatment correctly? Implications from a chronic care perspective.

Authors:  A Thomas McLellan
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

Review 2.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

Review 3.  Is there a case for extended interventions for alcohol and drug use disorders?

Authors:  James R McKay
Journal:  Addiction       Date:  2005-11       Impact factor: 6.526

4.  Protective resources and long-term recovery from alcohol use disorders.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  Drug Alcohol Depend       Date:  2007-01-05       Impact factor: 4.492

5.  The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.

Authors:  A J Rush; L M Koran; M B Keller; J C Markowitz; W M Harrison; R J Miceli; J A Fawcett; A J Gelenberg; R M Hirschfeld; D N Klein; J H Kocsis; J P McCullough; A F Schatzberg; M E Thase
Journal:  J Clin Psychiatry       Date:  1998-11       Impact factor: 4.384

6.  Pattern reliability of narcotics addicts' self-reported data: a confirmatory assessment of construct validity and consistency.

Authors:  C P Chou; Y I Hser; M D Anglin
Journal:  Subst Use Misuse       Date:  1996-07       Impact factor: 2.164

7.  Patterns of Crime and Drug Use Trajectories in Relation to Treatment Initiation and 5-Year Outcomes: An Application of Growth Mixture Modeling Across Three Datasets.

Authors:  Michael Prendergast; David Huang; Yih-Ing Hser
Journal:  Eval Rev       Date:  2008-02

8.  A follow-up of admissions to the California Civil Addict Program.

Authors:  W H McGlothlin; M D Anglin; B D Wilson
Journal:  Am J Drug Alcohol Abuse       Date:  1977       Impact factor: 3.829

9.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

10.  Methamphetamine use behaviors and gender differences.

Authors:  Mary-Lynn Brecht; Ann O'Brien; Christina von Mayrhauser; M Douglas Anglin
Journal:  Addict Behav       Date:  2004-01       Impact factor: 3.913

View more
  45 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  A Comparison of Methamphetamine Users to a Matched NHANES Cohort: Propensity Score Analyses for Oral Health Care and Dental Service Need.

Authors:  Debra A Murphy; Lauren Harrell; Rachel Fintzy; Thomas R Belin; Alexis Gutierrez; Steven J Vitero; Vivek Shetty
Journal:  J Behav Health Serv Res       Date:  2016-10       Impact factor: 1.505

3.  Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies.

Authors:  Brandon D L Marshall; Evan Wood; Jean A Shoveller; Jane A Buxton; Julio S G Montaner; Thomas Kerr
Journal:  Prev Sci       Date:  2011-06

4.  Trajectories of drug use and mortality outcomes among adults followed over 18 years.

Authors:  Stefan G Kertesz; Yulia Khodneva; Joshua Richman; Jalie A Tucker; Monika M Safford; Bobby Jones; Joseph Schumacher; Mark J Pletcher
Journal:  J Gen Intern Med       Date:  2012-01-25       Impact factor: 5.128

5.  Trajectories of heroin use: A 15-year retrospective study of Mexican-American men who were affiliated with gangs during adolescence.

Authors:  Kathryn M Nowotny; Jessica Frankeberger; Alice Cepeda; Avelardo Valdez
Journal:  Drug Alcohol Depend       Date:  2019-08-29       Impact factor: 4.492

6.  A Longitudinal Study of State Strategies and Policies to Accelerate Evidence-Based Practices in the Context of Systems Transformation.

Authors:  Traci Rieckmann; Amanda Abraham; Janet Zwick; Caitlin Rasplica; Dennis McCarty
Journal:  Health Serv Res       Date:  2014-12-23       Impact factor: 3.402

7.  Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing.

Authors:  Samantha J Fede; Carla L Harenski; Jana Schaich Borg; Walter Sinnott-Armstrong; Vikram Rao; Brendan M Caldwell; Prashanth K Nyalakanti; Michael R Koenigs; Jean Decety; Vince D Calhoun; Kent A Kiehl
Journal:  Psychopharmacology (Berl)       Date:  2016-07-12       Impact factor: 4.530

8.  Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.

Authors:  D M Coviello; R Lovato; K Apostol; M M Eisenberg; D S Metzger; R Szucs-Reed; N Kiryankova-Dalseth; D Kelly; A Jackson; M Plano; M B Blank
Journal:  Community Ment Health J       Date:  2018-05-11

Review 9.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

10.  Introduction to the special issue on "Statistical approaches and methodological issues in longitudinal analysis of substance use and related behaviors"

Authors:  Mary-Lynn Brecht; David Huang; Yih-Ing Hser
Journal:  J Drug Issues       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.